Abstract
No public abstract is available from the verified source records.
Michiel Coppens
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
One-stage assay factor VIII activity reflects AAV-derived factor VIII–enhanced thrombin activation and predicts phenotype
10.1182/blood.2025032890 · 2026
A critical appraisal of one-stage and chromogenic assays of factor VIII activity
10.1111/jth.13215 · 2016
Correlation between factor VIII chromogenic activity and antigen levels in patients treated with adeno-associated virus 5-mediated gene therapy for hemophilia A
10.1016/j.jtha.2026.04.017 · 2026
Unresolved referenced work
Kept as external metadata until matched
Durability of efficacy, safety, and quality of life 5 years after valoctocogene roxaparvovec gene transfer for severe hemophilia A: final phase 3 GENEr8-1 trial results
10.1016/j.rpth.2026.103416 · 2026
Unresolved referenced work
Kept as external metadata until matched
No additional external references are available.